EP0098475A3 - Pharmazeutische Zusammensetzung, ihre Herstellung und Verwendung - Google Patents

Pharmazeutische Zusammensetzung, ihre Herstellung und Verwendung Download PDF

Info

Publication number
EP0098475A3
EP0098475A3 EP83106168A EP83106168A EP0098475A3 EP 0098475 A3 EP0098475 A3 EP 0098475A3 EP 83106168 A EP83106168 A EP 83106168A EP 83106168 A EP83106168 A EP 83106168A EP 0098475 A3 EP0098475 A3 EP 0098475A3
Authority
EP
European Patent Office
Prior art keywords
pharmaceutical composition
manufacture
xipa
methyldopa
mid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP83106168A
Other languages
English (en)
French (fr)
Other versions
EP0098475A2 (de
Inventor
Rainer Dr. Dies
Bodo Dr. Asmussen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beiersdorf AG
Original Assignee
Beiersdorf AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beiersdorf AG filed Critical Beiersdorf AG
Publication of EP0098475A2 publication Critical patent/EP0098475A2/de
Publication of EP0098475A3 publication Critical patent/EP0098475A3/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Pharmazeutische Zusammensetzung, enthaltend Xipa­ mid und alpha-Methyldopa zur antihypertensiven Behand­ lung.
EP83106168A 1982-07-08 1983-06-24 Pharmazeutische Zusammensetzung, ihre Herstellung und Verwendung Withdrawn EP0098475A3 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3225491 1982-07-08
DE19823225491 DE3225491A1 (de) 1982-07-08 1982-07-08 Pharmazeutische zusammensetzung, ihre herstellung und verwendung

Publications (2)

Publication Number Publication Date
EP0098475A2 EP0098475A2 (de) 1984-01-18
EP0098475A3 true EP0098475A3 (de) 1985-06-12

Family

ID=6167904

Family Applications (1)

Application Number Title Priority Date Filing Date
EP83106168A Withdrawn EP0098475A3 (de) 1982-07-08 1983-06-24 Pharmazeutische Zusammensetzung, ihre Herstellung und Verwendung

Country Status (5)

Country Link
EP (1) EP0098475A3 (de)
JP (1) JPS5942318A (de)
AU (1) AU1652383A (de)
DE (1) DE3225491A1 (de)
ZA (1) ZA834539B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3247384B1 (de) 2015-01-14 2023-10-04 The Regents of the University of Colorado, a body corporate In vitro verfahren zur diagnose von typ-1-diabetes mit insulinmimotopen
CA2980940C (en) * 2015-05-28 2021-01-12 The Regents Of The University Of Colorado, A Body Corporate Methods of preventing and treating autoimmunity
US11052060B2 (en) 2018-02-12 2021-07-06 The Regents Of The University Of Colorado, A Body Corporate Compounds and methods for treating autoimmunity
US11013707B2 (en) 2018-03-23 2021-05-25 The Regents Of The University Of Colorado, A Body Corporate Administration of oral methyldopa

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2868818A (en) * 1953-12-15 1959-01-13 Merck & Co Inc Alpha methyl phenylalanines
GB936075A (en) * 1960-06-09 1963-09-04 Merck & Co Inc Therapeutic hypotensive compositions comprising phenylalanine derivatives and benzothiadiazine-1,1-dioxide derivatives
US3567777A (en) * 1965-06-19 1971-03-02 Beiersdorf P & Co Ag 4-chloro-5-sulfamyl salicylic acid-(2',6'-dimethyl) anilide

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2868818A (en) * 1953-12-15 1959-01-13 Merck & Co Inc Alpha methyl phenylalanines
GB936075A (en) * 1960-06-09 1963-09-04 Merck & Co Inc Therapeutic hypotensive compositions comprising phenylalanine derivatives and benzothiadiazine-1,1-dioxide derivatives
US3567777A (en) * 1965-06-19 1971-03-02 Beiersdorf P & Co Ag 4-chloro-5-sulfamyl salicylic acid-(2',6'-dimethyl) anilide

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
UNLISTED DRUGS, Band 19, Nr.10, Oktober 1967, Seite 138, CHATHAM, NEW JERSEY, (US). * SEITE 138H "TADIP" * *
UNLISTED DRUGS, Band 22, Nr.3, Marz 1970, Seite 42, CHATHAM, NEW JERSEY, (US).* SEITE 42F "SEMBRINA-SALTUCIN" * *
UNLISTED DRUGS, Band 23, Nr.12, Dezember 1971, Seite 178, CHATHAM, NEW JERSEY, (US). * SEITE 178D " DUROTAN 100" * *
UNLISTED DRUGS, Band 24, Nr. 12, Dezember 1972, Seite 185, CHATHAM, NEW JERSEY, (US). * SEITE 185P *CAPRINOL" * *

Also Published As

Publication number Publication date
EP0098475A2 (de) 1984-01-18
JPS5942318A (ja) 1984-03-08
DE3225491A1 (de) 1984-01-12
AU1652383A (en) 1985-01-10
ZA834539B (en) 1984-03-28

Similar Documents

Publication Publication Date Title
EE9700044A (et) Heteroarüüloksasolidinoonid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid.
DE68905939D1 (de) Infektionsresistente zusammensetzungen, medizinische geraete und oberflaechen und verfahren zur herstellung und gebrauch derselben.
ATE84215T1 (de) Arzneizubereitung zur oralen anwendung.
DE3875749D1 (de) Absorbierende zusammensetzung.
EE9700020A (et) Heteroaatomit sisaldavad tsülopentaanpüridüüloksasolidinoonid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid
EE9700043A (et) Asendatud oksasolidinoonid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid
DE3680578D1 (de) Dipeptid-derivate, verfahren zur herstellung, pharmazeutische zusammensetzungen und ihre anwendung.
FI881177A (fi) Anordning foer positionering av en patient i en medicinsk panoramaroentgenfotograferingsanordning.
DE3781569D1 (de) Mittel zur oralen verwendung.
DE3485408D1 (de) Pharmazeutische zusammensetzung.
DE69004739D1 (de) Einrichtung zur Vorbereitung medizinischer Lösungen.
FI841448A0 (fi) Anordning foer upprullning av en materialbana, speciellt en pappersbana, pao en hylsa.
DE69019345D1 (de) Zusammensetzung zur behandlung von samen.
DE3667605D1 (de) Windel zur verhuetung von wundliegen.
DE3382112D1 (de) Pharmazeutische zusammensetzung.
EP0098475A3 (de) Pharmazeutische Zusammensetzung, ihre Herstellung und Verwendung
DK133587A (da) 2-heterocyclylthio-penemer, deres anvendelse og farmaceutisk komposition indeholdende forbindelserne
ATE89826T1 (de) Antibakterielle verbindungen, ihre herstellung und verwendung.
ATE96142T1 (de) Triglyceridquartaerammonium-verbindungen, ihre herstellung und anwendung.
NO893064D0 (no) Sekundaere polyeteraminer, deres fremstilling og anvendelse for fremstilling av polyureaforbindelser.
IT8320023A0 (it) Carbacicline, procedimento per laloro preparazione e loro impiegocome medicinali.
ATE8798T1 (de) Kijanimicin, es enthaltende pharmazeutische zusammensetzungen und verfahren zur herstellung von kijanimicin und der zusammensetzungen.
DE68919887D1 (de) Verfahren zur Herstellung von 1-alpha,25-dihydroxy-vitamin D2 und dessen 24-Epimer.
DK406589A (da) Middel til behandling af maligne tumorer, indeholdende 8-chloradenosin-3',5'-cyclisk phosphat, 8-aminoacenosin-3',5'-cyclisk phosphat
NO885406D0 (no) Fremgangsmaate for fremstilling av 4-heteroaryl-1,3-benzodiazepiner og 2-substituerte-alfa-(hetero-aryl)benzenetanaminer og anvendelse derav som medikamenter.

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19830624

AK Designated contracting states

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

17Q First examination report despatched

Effective date: 19861031

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19870311

RIN1 Information on inventor provided before grant (corrected)

Inventor name: DIES, RAINER, DR.

Inventor name: ASMUSSEN, BODO, DR.